LBRX β€” LB PHARMACEUTICALS INC

Ownership history in TCG Crossover Management, LLC  Β·  2 quarters on record

This page tracks every 13F SEC filing in which TCG Crossover Management, LLC reported a position in LB PHARMACEUTICALS INC (LBRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

πŸ” Peak position
1.36% (2025 Q3)
πŸ“Š Avg. % of fund
1.32%
πŸ“… First filed
2025 Q3
πŸ“… Last filed
2025 Q4
⏱ Quarters held
2
% of Fund (quarterly)    LBRX price (monthly, adj. close)
πŸ“‹ Quarterly Holdings History 2 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 1,745,015 -1 -0.0% 1.29% $38.8M $22.26
2025 Q3 INITIATED 1,745,016 β€” β€” 1.36% $27.6M $15.79

🏒 Other funds also holding LBRX

As of 2025 Q4 β€” sorted by position size

Nan Fung Group Holdings Ltd 3Y 5.98% Commodore Capital LP 3Y 2.22% Logos Global Management LP 3Y 1.61% Deep Track Capital, LP 3Y 1.33% Vivo Capital, LLC 3Y 7Y 1.15% HighVista Strategies LLC 3Y 7Y 0.8% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 0.5% Nantahala Capital Management, LLC 3Y 7Y 0.5% ACUTA CAPITAL PARTNERS, LLC 3Y 7Y 0.45% Longbow Finance SA 3Y 0.31%
← Back to TCG Crossover Management, LLC Holdings